Caricamento...

A Mechanistically Novel, First Oral Therapy for Multiple Sclerosis: The Development of Fingolimod (FTY720, Gilenya)

Multiple sclerosis (MS) is a chronic autoimmune disorder affecting the central nervous system (CNS) through demyelination and neurodegeneration. Until recently, major therapeutic treatments have relied on agents requiring injection delivery. In September 2010, fingolimod/FTY720 (Gilenya, Novartis) w...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Chun, Jerold, Brinkmann, Volker
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2011
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3694567/
https://ncbi.nlm.nih.gov/pubmed/21955849
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !